Items where authors include "Langley, R.E."

Article

Kloft, M., Budginaite, E., van Kuijk, S.M.J. et al. (7 more authors) (2025) Intra-patient comparison of microarchitecture of tumour negative lymph nodes from oesophageal cancer patients – Results from the MRC Oe02 trial. Pathology - Research and Practice, 266. 155818. ISSN 0344-0338

Sydes, M.R., Murray, M.L., Ahmed, S. et al. (25 more authors) (2024) Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials. Contemporary Clinical Trials, 141. 107514. ISSN 1551-7144

Grosser, B., Emmerson, J. orcid.org/0000-0002-8198-8043, Reitsam, N.G. orcid.org/0000-0002-0070-3158 et al. (7 more authors) (2024) Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British Journal of Cancer, 130 (3). pp. 457-466. ISSN 0007-0920

Beuque, M., Magee, D.R. orcid.org/0000-0003-2170-3103, Chatterjee, A. et al. (7 more authors) (2023) Automated detection and delineation of lymph nodes in haematoxylin & eosin stained digitised slides. Journal of Pathology Informatics, 14. 100192. ISSN 2229-5089

Parker, C.C., James, N.D. orcid.org/0000-0002-7314-8204, Brawley, C.D. orcid.org/0000-0003-3641-278X et al. (43 more authors) (2022) Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial. PLOS Medicine, 19 (6). e1003998. ISSN 1549-1277

Clarke, N.W., Ali, A., Ingleby, F.C. et al. (47 more authors) (2019) Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial. Annals of Oncology, 30 (12). pp. 1992-2003. ISSN 0923-7534

Cunningham, D., Stenning, S.P., Smyth, E.C. et al. (15 more authors) (2017) Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial. The Lancet Oncology, 18 (3). pp. 357-370. ISSN 1470-2045

Mulvenna, P., Nankivell, M., Barton, R. et al. (16 more authors) (2016) Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. The Lancet, 388 (10055). pp. 2004-2014. ISSN 0140-6736

Conference or Workshop Item

Kloft, M., Budginaite, E., Raghuram, G. et al. (8 more authors) (2025) 457P Size of the largest nonmetastatic regional lymph node: A validated prognostic marker in patients with esophageal, junctional or gastric adenocarcinoma. In: ESMO Gastrointestinal Cancers Congress 2025, 02-05 Jul 2025, Barcelona, Spain.